Cargando…
Large-scale in-silico identification of a tumor-specific antigen pool for targeted immunotherapy in triple-negative breast cancer
Since the advent of cetuximab, clinical cancer treatment has evolved from the standard, relatively nonspecific chemo- and radiotherapy with significant cytotoxic side effects towards immunotherapeutic approaches with selective, target-mechanism-based effects. Antibody therapies as the most successfu...
Autores principales: | Kaufmann, Jessica, Wentzensen, Nicolas, Brinker, Titus J., Grabe, Niels |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493464/ https://www.ncbi.nlm.nih.gov/pubmed/31069014 http://dx.doi.org/10.18632/oncotarget.26808 |
Ejemplares similares
-
In silico design of a triple-negative breast cancer vaccine by targeting cancer testis antigens
por: Parvizpour, Sepideh, et al.
Publicado: (2019) -
Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021) -
Robust and accurate quantification of biomarkers of immune cells in lung cancer micro-environment using deep convolutional neural networks
por: Aprupe, Lilija, et al.
Publicado: (2019) -
Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?
por: Hendrickx, Wouter, et al.
Publicado: (2015) -
Immunotherapy Treatment for Triple Negative Breast Cancer
por: Berger, Elizabeth R., et al.
Publicado: (2021)